Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLESP Block vs PAI for Pain After THA
NCT06688136Completed
- Sponsor
- Huazhong University of Science and Technology
- Start
- Nov 2024
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Cumulative Opioid Consumption at 24 hours. Started Nov 2024; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06688136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06688136.